Massachusetts-based pharmaceutical and biotechnology giant Moderna has announced an agreement in principle with the Australian government to establish a state-of-the-art mRNA vaccine production facility in Victoria, Australia.
Moderna expects that up to 100 million vaccine doses could be produced in Australia each year.
Go deeper with GlobalData
Chief executive officer Stéphane Bancel commented: “I would like to thank the Australian and Victorian governments for their collaboration and partnership. We are committed to global public health and while we are still responding to this pandemic, we also want to ensure we and society learn from it. As Moderna expands internationally, we are pleased to bring local mRNA manufacturing to Australia. We believe that this sustainable national business model will have global impact and implications.”
The new production facility is expected to provide Australians with direct access to a domestically manufactured portfolio of mRNA vaccines against respiratory viruses. These will include Covid-19, seasonal influenza, respiratory syncytial virus and potential other vaccines pending licensure.
In addition, the facility is intended to be activated on an urgent basis to support the country with direct access to rapid pandemic response capabilities.
Moderna is in discussion with other governments about potential collaborations built on a similar model. The company announced plans to build a facility in Canada earlier in 2021.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
